2017-4-3

İbrahim Gündoğmuş ve ark.
BOĞAZİÇİ TIP DERGİSİ; 2017; 4 (3):158-160 - Doi: 10.15659/bogazicitip.17.10.702
3. Lavigne GJ, Kato T, Kolta A, Sessle BJ. Neurobiological
mechanisms involved in sleep bruxism. Crit Rev Oral
Biol Med. 2003;14(1):30-46.
4. Lobbezoo F, van Denderen RJ, Verheij JG, Naeije M.
Reports of SSRI-associated bruxism in the family physician’s
office. J Orofac Pain. 2001;15(4):340-6.
5. Anderson IM, Nutt DJ, Deakin JF. Evidence-based
guidelines for treating depressive disorders with antidepressants:
a revision of the 1993 British Association for Psychopharmacology
guidelines. British Association for Psychopharmacology.
J Psychopharmacol. 2000;14(1):3-20.
6. Lachkar Y, Bouassida W. Drug-induced acute angle
closure glaucoma. Curr Opin Ophthalmol. 2007;18(2):129-
33. doi: 10.1097/ICU.0b013e32808738d5.
7. Hyttel J. Citalopram--pharmacological profile of
a specific serotonin uptake inhibitor with antidepressant
activity. Prog Neuropsychopharmacol Biol Psychiatry.
1982;6(3):277-95.
8. Wise M. Citalopram-induced bruxism. Br J Psychiatry.
2001;178:182.
9. Sabuncuoglu O, Ekinci O, Berkem M. Fluoxetineinduced
sleep bruxism in an adolescent treated with buspirone:
a case report. Spec Care Dentist. 2009;29(5):215-
7.
10. Kishi Y. Paroxetine-induced bruxism effectively treated
with tandospirone. J Neuropsychiatry Clin Neurosci.
2007;19(1):90-1. doi: 10.1176/jnp.2007.19.1.90.
11. Bostwick JM, Jaffee MS. Buspirone as an antidote
to SSRI-induced bruxism in 4 cases. J Clin Psychiatry.
1999;60(12):857-60.
12. Raja M, Raja S. Two cases of sleep bruxism associated
with escitalopram treatment. J Clin Psychopharmacol.
2014;34(3):403-5.
13. Grinshpoon A, Weizman A, Amrami-Weizman A. The
beneficial effect of trazodone treatment on escitalopramassociated
nocturnal bruxism. J Clin Psychopharmacol.
2014;34(5):662.
14. Lobbezoo F, Lavigne GJ, Tanguay R, Montplaisir JY.
The effect of catecholamine precursor L-dopa on sleep bruxism:
a controlled clinical trial. Mov Disord. 1997;12(1):73-8.
15. Tanda G, Carboni E, Frau R, Di Chiara G. Increase
of extracellular dopamine in the prefrontal cortex: a trait of
drugs with antidepressant potential? Psychopharmacology
(Berl). 1994;115(1-2):285-8.
16. Jaffee MS, Bostwick JM. Buspirone as an antidote
to venlafaxine-induced bruxism. Psychosomatics.
2000;41(6):535-6.
17. Winocur E, Gavish A, Voikovitch M, Emodi-Perlman
A, Eli I. Drugs and bruxism: a critical review. J Orofac
Pain. 2003;17(2):99-111.
18. See SJ, Tan EK. Severe amphethamine-induced bruxism:
treatment with botulinum toxin. Acta Neurol Scand.
2003;107(2):161-3.
-160-